237 related articles for article (PubMed ID: 21971378)
21. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
22. Nonabsorbable disaccharides for hepatic encephalopathy.
Als-Nielsen B; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
[TBL] [Abstract][Full Text] [Related]
24. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
Jiang Q; Jiang XH; Zheng MH; Chen YP
J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
[TBL] [Abstract][Full Text] [Related]
25. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
26. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
Burkard T; Biedermann A; Herold C; Dietlein M; Rauch M; Diefenbach M
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):352-8. PubMed ID: 23117470
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
28. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
29. Structured triglyceride for parenteral nutrition: meta-analysis of randomized controlled trials.
Zhou Y; Wu XT; Li N; Zhuang W; Liu G; Wu T; Wei ML
Asia Pac J Clin Nutr; 2006; 15(3):406-11. PubMed ID: 16837434
[TBL] [Abstract][Full Text] [Related]
30. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
[TBL] [Abstract][Full Text] [Related]
31. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
32. [Meta-analysis of lumbar posterolateral fusion versus circumferential fusion in the treatment of the lumbar disease].
Cui C; Zhu Y; Han XX
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(18):1374-8. PubMed ID: 20092769
[TBL] [Abstract][Full Text] [Related]
33. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
[TBL] [Abstract][Full Text] [Related]
34. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
[TBL] [Abstract][Full Text] [Related]
35. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
[TBL] [Abstract][Full Text] [Related]
36. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
Malaguarnera M; Gargante MP; Malaguarnera G; Salmeri M; Mastrojeni S; Rampello L; Pennisi G; Li Volti G; Galvano F
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):199-206. PubMed ID: 19730107
[TBL] [Abstract][Full Text] [Related]
37. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
Shen YC; Chang YH; Fang CJ; Lin YS
Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
Abid S; Jafri W; Mumtaz K; Islam M; Abbas Z; Shah HA; Hamid S
J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
[TBL] [Abstract][Full Text] [Related]
40. [Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy].
Nie YQ; Zeng Z; Li YY; Sha WH; Ping L; Dai SJ
Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):261-3. PubMed ID: 12887812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
